E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/4/2013 in the Prospect News PIPE Daily.

Nephros reports plans for $3 million rights offering of common stock

Shareholders receive subscription rights to buy shares at $0.60 apiece

By Devika Patel

Knoxville, Tenn., March 4 - Nephros, Inc. plans a rights offering to raise up to $3 million, according to a Form S-1 filed Monday with the Securities and Exchange Commission.

The company will offer rights for up to 5 million common shares. Each subscription right will entitle its holder to purchase a common share at the subscription price of $0.60, a 36.84% discount to the closing share price of $0.95 on March 1.

Proceeds will be used to repay debt and for general corporate purposes, including working capital and operating expenses.

Nephros is a New York-based medical device company.

Issuer:Nephros, Inc.
Issue:Common stock
Amount:$3 million
Shares:5 million
Price:$0.60
Warrants:No
Pricing date:March 4
Stock symbol:OTCBB: NEPH
Stock price:$0.95 at close March 1
Market capitalization:$11.45 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.